A Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults
This study has been completed.
Sponsor:
MedImmune LLC
Collaborator:
AstraZeneca, PLC
Information provided by (Responsible Party):
MedImmune LLC
ClinicalTrials.gov Identifier:
NCT01579916
First received: April 16, 2012
Last updated: January 7, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | December 2012 |
| Primary Completion Date: | November 2012 (Final data collection date for primary outcome measure) |